The effects of antioxidants and hypohalous acid scavengers on neutrophil activation by hypochlorous acid-modified low-density lipoproteins
- Авторы: Panasenko O.M.1,2, Mikhalchik E.V.1, Gorudko I.V.3, Grigorieva D.V.3, Sokolov A.V.1,4,5, Kostevich V.A.1,4, Vasilyev V.B.4,5, Cherenkevich S.N.3
-
Учреждения:
- Research Institute of Physico-chemical Medicine
- Ministry of Health and Social Development of the Russian Federation
- Belarussian State University
- Institute of Experimental Medicine
- St. Petersburg State University
- Выпуск: Том 61, № 3 (2016)
- Страницы: 420-428
- Раздел: Cell Biophysics
- URL: https://ogarev-online.ru/0006-3509/article/view/151996
- DOI: https://doi.org/10.1134/S0006350916030131
- ID: 151996
Цитировать
Аннотация
Hypochlorous acid-modified human blood low density lipoprotein (LDL–HOCl) was shown to stimulate neutrophils and to increase the luminol- (lm-CL) or lucigenin-enhanced chemiluminescence (lc-CL) of neutrophils. Antioxidants and HOCl scavengers (glutathione, taurine, cysteine, methionine, ceruloplasmin, and human serum albumin (HSA)) were tested for effects on lm-CL, lc-CL, H2O2 production, and degranulation of azurophilic granules of neutrophils. All agents used in increasing concentrations were found to decrease lm-CL produced by neutrophils upon stimulation with LDL–HOCl or subsequent treatment with the activator phorbol 12-myristate 13-acetate (PMA). The agents exerted a far lower, if any, effect on lc-CL and the H2O2 production by neutrophils in the same conditions. In the majority of cases, a decline in neutrophil chemiluminescence in the presence of the agents was not related to their effect on neutrophil degranulation, but was most likely due to their direct interactions with reactive halogen (RHS) or oxygen (ROS) species generated upon neutrophil activation or to myeloperoxidase (MPO) inhibition. Antioxidants and HOCl scavengers present in the human body were assumed to decelerate the development of oxidative or halogenative stress and thereby prevent neutrophil activation.
Об авторах
O. Panasenko
Research Institute of Physico-chemical Medicine; Ministry of Health and Social Development of the Russian Federation
Автор, ответственный за переписку.
Email: o-panas@mail.ru
Россия, ul. Malaya Pirogovskaya 1a, Moscow, 119435; ul. Ostrovityanova 1, Moscow, 117997
E. Mikhalchik
Research Institute of Physico-chemical Medicine
Email: o-panas@mail.ru
Россия, ul. Malaya Pirogovskaya 1a, Moscow, 119435
I. Gorudko
Belarussian State University
Email: o-panas@mail.ru
Белоруссия, pr. Nezavisimosti 4, Minsk, 220050
D. Grigorieva
Belarussian State University
Email: o-panas@mail.ru
Белоруссия, pr. Nezavisimosti 4, Minsk, 220050
A. Sokolov
Research Institute of Physico-chemical Medicine; Institute of Experimental Medicine; St. Petersburg State University
Email: o-panas@mail.ru
Россия, ul. Malaya Pirogovskaya 1a, Moscow, 119435; ul. Akademika Pavlova 12, St. Petersburg, 197376; Universitetskaya nab. 7/9, St. Petersburg, 199034
V. Kostevich
Research Institute of Physico-chemical Medicine; Institute of Experimental Medicine
Email: o-panas@mail.ru
Россия, ul. Malaya Pirogovskaya 1a, Moscow, 119435; ul. Akademika Pavlova 12, St. Petersburg, 197376
V. Vasilyev
Institute of Experimental Medicine; St. Petersburg State University
Email: o-panas@mail.ru
Россия, ul. Akademika Pavlova 12, St. Petersburg, 197376; Universitetskaya nab. 7/9, St. Petersburg, 199034
S. Cherenkevich
Belarussian State University
Email: o-panas@mail.ru
Белоруссия, pr. Nezavisimosti 4, Minsk, 220050
Дополнительные файлы
